Archives

Cardiol Therapeutics’ Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association

B Results demonstrate CardiolRx™ may represent a paradigm shift in the treatment of patients with recurrent pericarditis and further validate the ongoing Phase III trial,… Login to continue reading Login…

Read MoreCardiol Therapeutics’ Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association

Wegovy® access expanded for Medicare beneficiaries living with obesity through the Medicare GLP-1 Bridge starting July 1, 2026

B Eligible Medicare patients living with obesity will have access to Wegovy® (semaglutide) injection and pill for a $50 monthly copay Wegovy® offers adults living… Login to continue reading Login…

Read MoreWegovy® access expanded for Medicare beneficiaries living with obesity through the Medicare GLP-1 Bridge starting July 1, 2026